| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| General health | 2 | 0 | |
| Parkinson's disease | 2 | 1 | |
| Ehlers-Danlos syndrome | 1 | 0 | |
| Exercise intolerance | 1 | 0 | |
| Fainting | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 2 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| General health | 2 | 0 | |
| Parkinson's disease | 2 | 1 | |
| Ehlers-Danlos syndrome | 1 | 0 | |
| Exercise intolerance | 1 | 0 | |
| Fainting | 1 | 0 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 2 |